글로벌 피부과 엑시머 레이저 시장 – 2023-2030

Overview
Global dermatology excimer laser market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing at a CAGR of YY% during the forecast period 2023-2030.
Dermatology excimer laser is a device used for laser therapy by using the laser beam with ultraviolet B (UVB) light to treat the affected areas of skin. Any area of the body can be treated with this laser therapy, including the scalp. The treatment of various skin conditions with these lasers is considered highly effective, safe and painless. The excimer laser treats only the affected areas of skin as opposed to a phototherapy unit which treats all exposed skin. Treatment time is typically less than 10-15 minutes.
Moreover, in dermatology excimer lasers, light travels in waves, some types of light waves are very long and other wavelengths are quite short. Light of different wavelengths can have different effects on the body. This wavelength of light can eliminate the overactive immune cells that cause symptoms of eczema and can help re-pigment skin affected by vitiligo. Excimer laser treatments can also treat psoriasis when the condition is confined to smaller patches of skin, such as the elbows, hands, feet, or scalp. These lasers are most commonly used for such skin conditions.
Market Dynamics: Drivers
Increasing adoption and increasing advancements in excimer lasers
The increasing adoption of dermatology excimer lasers in various skin disorders and increasing advancements in excimer lasers are expected to drive the market over the forecast period. Ongoing advancements in dermatology excimer laser technology led to even more precise and customizable treatment options, especially for vitiligo and psoriasis. This results in reduced damage to healthy tissue and quicker, more effective treatments.
For instance, on February 09, 2022, STRATA Skin Sciences, Inc. launched the first installation in the U.S. market, of its next-generation excimer laser system, XTRAC Momentum 1.0. The XTRAC excimer laser technology allows for the precise delivery of targeted UVB light therapy to specific skin treatment areas, for both adult and pediatric patients suffering from inflammatory skin conditions such as psoriasis, atopic dermatitis and vitiligo.
Moreover, STRATA’s new XTRAC Momentum 1.0 represents the latest in excimer laser technology, delivering higher power and a faster repetition rate than the current models. The Momentum also offers a new user interface and slim design, both intended to improve the treatment experience.
In addition, excimer lasers are particularly effective in treating psoriasis. They offer precise targeting of affected areas, reducing exposure to healthy skin. This has led to increased adoption of excimer lasers as a primary treatment option for psoriasis patients. The targeted nature of excimer laser therapy is also beneficial for vitiligo patients, where it can help repigment the affected areas. Patients are increasingly seeking non-invasive and highly targeted treatments, contributing to the adoption of the dermatology excimer lasers.
For instance, on August 12, 2020, LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology, launched its PALLAS Solid-State 311nm UVB laser in the United States. The efficacious and safe PALLAS laser is FDA-cleared for the treatment of vitiligo, psoriasis, atopic dermatitis and leukoderma. PALLAS features unique technology improvements over 308-nanometer excimer lasers.
Further, the increasing prevalence of chronic skin conditions like psoriasis, vitiligo, eczema and others, rising FDA approvals for more advanced lasers, increasing awareness and advancements in the development of more precise excimer lasers are the factors expected to drive the market over the forecast period.
Restraints
Factors such as complications associated with dermatology excimer lasers, high cost of the excimer laser therapy, side effects associated with these laser techniques and lack of awareness about the excimer lasers are expected to hamper the market.
Segment Analysis
The global dermatology excimer laser market is segmented based on product type, application, end-user and region.
The psoriasis segment accounted for approximately 49.8% of the dermatology excimer laser market share
The psoriasis segment is expected to hold the largest market share over the forecast period. The dermatology excimer lasers emit a specific wavelength of ultraviolet B light, which can be precisely targeted to affected areas of the skin. This focused treatment minimizes exposure to healthy skin, reducing the risk of side effects commonly associated with broader UVB exposure. In case of psoriasis, excimer lasers are used to slow down the growth of skin cells in affected areas and reduce inflammation, helping to manage and alleviate the symptoms of psoriasis.
Additionally, using excimer lasers for psoriasis patients results in faster clearing of psoriatic lesions compared to other treatment methods and the therapy is generally well-tolerated so this therapy is most commonly used. Patients are mostly preferring this therapy due to its non-invasive nature.
Moreover, the increasing prevalence of psoriasis is expected to the increasing adoption of dermatology excimer lasers. For psoriasis patients, excimer laser therapy provides relief that lasts several months, improves symptoms in just 6-12 sessions, is known for a quick, easy treatment that doesn’t require to application of creams or products every day, provides long-term symptom remission and it also provides pain-free and non-invasive treatment.
For instance, according to the National Psoriasis Foundation, 2022, more than 8 million Americans have psoriasis. 125 million people worldwide, 2 to 3 percent of the total population have psoriasis, according to the World Psoriasis Day consortium. Psoriasis prevalence in African Americans is 1.5 percent compared to 3.6 percent of Caucasians.
Geographical Analysis
North America accounted for approximately 40.4% of the market share
North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of dermatology excimer lasers to treat various types of skin conditions. North America especially the United States is known for its strong presence of major players such as medical device companies and biotechnology companies which are actively focussing on the development of more advanced and precise dermatology excimer lasers for better patient outcomes. This presence of major players performs research activities for the advancements in the excimer lasers.
Furthermore, increasing adoption of dermatology excimer lasers is also expected to drive the market in the region. The region is also known for the increasing prevalence of various skin conditions, this increasing prevalence is expected to increase the demand and adoption of dermatology excimer lasers.
For instance, according to the National Eczema Association, 31.6 million people in the U.S. have some form of eczema, and prevalence peaks during early childhood and according to the National Psoriasis Foundation, more than 8 million Americans have psoriasis. This increasing prevalence of skin conditions in the region is expected to increase the adoption of dermatology excimer lasers for better treatment of skin disorders.
Competitive Landscape
The major global players in the dermatology excimer laser market include STRATA Skin Sciences, Inc., Shenzhen GSD Tech Co., Ltd., Alma Lasers, Kernel Medical Equipment Co., LTD., Timpac Healthcare Pvt. Ltd., KRUPA MEDI SCAN, Komachine Inc., Optosystems Ltd., DermSA and PhotoMedex, Inc. among others.
COVID-19 Impact Analysis
The COVID-19 pandemic significantly impacted the global dermatology excimer laser market. During the pandemic, patients with dermatological conditions like psoriasis, who would have otherwise sought treatment with excimer lasers are delayed or avoided in-person visits to healthcare facilities. This was due to concerns and redirected focus towards virus exposure, restrictions on non-essential healthcare services and the reprioritization of healthcare resources. The pandemic also disrupted the supply chain of these medical devices globally due to border closures.
Market Segmentation
By Product Type
• Table Top Excimer Lasers
• Hand-Held Excimer Lasers
• Trolley Mounted Excimer Lasers
By Application
• Vitiligo
• Psoriasis
• Eczema
• White Scars
• Others
By End-User
• Hospitals
• Dermatology Clinics
• Specialty Clinics
• Laser Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Why Purchase the Report?
• To visualize the global dermatology excimer laser market segmentation based on product type, application, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of dermatology excimer laser market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global dermatology excimer laser market report would provide approximately 61 tables, 61 figures, and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies